Diabetes 50:425-435, 2001
© 2001 by the American Diabetes Association, Inc.
Transgenic Complementation of Leptin-Receptor Deficiency
I. Rescue of the Obesity/Diabetes Phenotype of LEPR-Null Mice Expressing a LEPR-B Transgene
Timothy J. Kowalski,
Shun-Mei Liu,
Rudolph L. Leibel, and
Streamson C. Chua, Jr.
From the Department of Pediatrics, Division of Molecular Genetics and
Naomi Berrie Diabetes Center, Columbia University College of Physicians and
Surgeons, New York, New York.
Address correspondence and reprint requests to Streamson C. Chua, Jr., MD,
PhD, Department of Pediatrics, Division of Molecular Genetics, Columbia
University College of Physicians and Surgeons, Russ Berrie Medical Science
Pavilion, 1150 St. Nicholas Ave., New York, NY 10032. E-mail:
sc569{at}columbia.edu
.
Mice homozygous for the Leprdb3J
(db3J) mutation are null for all known isoforms of the
leptin receptor (LEPR). These animals are obese, hyperphagic, cold intolerant,
insulin resistant, and infertile. Mice homozygous for the
Leprdb (db) mutation (lacking the B isoform only)
have the same phenotype as db3J animals. To better
understand the function(s) of the LEPR isoforms in vivo, we generated
db3J/db3J and db/db mice bearing a
transgene (neuron-specific enolase [NSE]-Rb) expressing the B isoform of LEPR,
the isoform capable of activating the signal transducer and activator of
transcription (STAT) pathway, under the control of the neuron-specific enolase
enhancer/promoter. The NSE-Rb transgene was expressed in the brain, with low
levels of expression in adrenals, testis, and white adipose tissue. LEPR-B
transgene expression in NSE-Rb db3J/db3J mice
partially corrected the increased fat mass, hyperphagia, and glucose
intolerance while restoring fertility in males and rescuing the cold
intolerance in both sexes. The body weights of NSE-Rb transgenic mice that
possessed the full complement of short LEPR isoforms (NSE-Rb db/db
mice) were similar to those of NSE-Rb db3J/db3J
mice, suggesting that the short LEPR isoforms play little role in body weight
regulation. Based on quantitative analysis of hypothalamic neuropeptide gene
expression in the transgenic animals, we infer full restoration of leptin
sensitivity to proopiomelanocortin (POMC) neurons, partial correction of
leptin sensitivity in agouti gene-related protein (AGRP)/neuropeptide Y (NPY)
neurons, and a lack of effect on leptin sensitivity of melanin concentrating
hormone neurons. Thus, hypothalamic POMC and AGRP/NPY neurons are primary
candidates as the mediators of the effects of the NSE-Rb transgene on energy
homeostasis, ingestive behavior, the neuroen-docrine system, and glucose
metabolism.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Gong, R. Ishida-Takahashi, E. C. Villanueva, D. C. Fingar, H. Munzberg, and M. G. Myers Jr.
The Long Form of the Leptin Receptor Regulates STAT5 and Ribosomal Protein S6 via Alternate Mechanisms
J. Biol. Chem.,
October 19, 2007;
282(42):
31019 - 31027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. McMinn, S.-M. Liu, H. Liu, I. Dragatsis, P. Dietrich, T. Ludwig, C. N. Boozer, and S. C. Chua Jr.
Neuronal deletion of Lepr elicits diabesity in mice without affecting cold tolerance or fertility
Am J Physiol Endocrinol Metab,
September 1, 2005;
289(3):
E403 - E411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Cohen, G. Yang, X. Yu, A. A. Soukas, C. S. Wolfish, J. M. Friedman, and C. Li
Induction of Leptin Receptor Expression in the Liver by Leptin and Food Deprivation
J. Biol. Chem.,
March 18, 2005;
280(11):
10034 - 10039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Savontaus, T. L. Breen, A. Kim, L. M. Yang, S. C. Chua Jr., and S. L. Wardlaw
Metabolic Effects of Transgenic Melanocyte-Stimulating Hormone Overexpression in Lean and Obese Mice
Endocrinology,
August 1, 2004;
145(8):
3881 - 3891.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Genetically Modified Animals in Endocrinology
Endocr. Rev.,
June 1, 2004;
25(3):
512 - 519.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Yang, H. Ge, A. Boucher, X. Yu, and C. Li
Modulation of Direct Leptin Signaling by Soluble Leptin Receptor
Mol. Endocrinol.,
June 1, 2004;
18(6):
1354 - 1362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. R. DeRubertis, P. A. Craven, M. F. Melhem, and E. M. Salah
Attenuation of Renal Injury in db/db Mice Overexpressing Superoxide Dismutase: Evidence for Reduced Superoxide-Nitric Oxide Interaction
Diabetes,
March 1, 2004;
53(3):
762 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Chua Jr., S. M. Liu, Q. Li, A. Sun, W. F. DeNino, S. B. Heymsfield, and X. E. Guo
Transgenic complementation of leptin receptor deficiency. II. Increased leptin receptor transgene dose effects on obesity/diabetes and fertility/lactation in lepr-db/db mice
Am J Physiol Endocrinol Metab,
March 1, 2004;
286(3):
E384 - E392.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Bjorbaek and B. B. Kahn
Leptin Signaling in the Central Nervous System and the Periphery
Recent Prog. Horm. Res.,
January 1, 2004;
59(1):
305 - 331.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J.-N. Huan, J. Li, Y. Han, K. Chen, N. Wu, and A. Z. Zhao
Adipocyte-selective Reduction of the Leptin Receptors Induced by Antisense RNA Leads to Increased Adiposity, Dyslipidemia, and Insulin Resistance
J. Biol. Chem.,
November 14, 2003;
278(46):
45638 - 45650.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|